Oric Pharmaceuticals, Inc. (ORIC)
11.90
+0.14
(+1.19%)
USD |
NASDAQ |
Mar 13, 16:00
11.89
-0.01
(-0.08%)
After-Hours: 20:00
Oric Pharmaceuticals Shareholders Equity (Quarterly) : 384.36M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 8.658B |
| Gilead Sciences, Inc. | 22.70B |
| Johnson & Johnson | 81.54B |
| Krystal Biotech, Inc. | 1.220B |
| Olema Pharmaceuticals, Inc. | 307.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 411.00M |
| Total Liabilities (Quarterly) | 26.64M |
| Debt to Equity Ratio | 0.0194 |
| Current Ratio | 14.13 |
| Net Debt Paydown Yield | -0.11% |